Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk
about
Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol dietsThe role of the arginine metabolome in pain: implications for sickle cell diseaseRight ventricular afterload and the role of nitric oxide metabolism in left-sided heart failureGenetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred StrainsGenome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levelsIncreased plasma citrulline in mice marks diet-induced obesity and may predict the development of the metabolic syndromeArginase promotes endothelial dysfunction and hypertension in obese ratsArginine deprivation and immune suppression in a mouse model of Alzheimer's diseaseDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaArginases and arginine deficiency syndromesOverexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissuePlasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension.Cardioprotection and lifespan extension by the natural polyamine spermidine.Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumoniaMetabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.Nitric Oxide-Related Biological Pathways in Patients with Major DepressionIncreased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension.Arginine de novo and nitric oxide production in disease states.Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery diseasePulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failureGlobal arginine bioavailability in Tanzanian sickle cell anaemia patients at steady-state: a nested case control study of deaths versus survivors.Profiling of plasma metabolites in postmenopausal women with metabolic syndromeParadoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertensionA randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesArgininemia and plasma arginine bioavailability - predictive factors of mortality in the severe trauma patients?Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis.Translating metabolomics to cardiovascular biomarkers.New and emerging biomarkers in cardiovascular disease.When Is It Appropriate to Use Arginine in Critical Illness?Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.A new metabolomic assay to examine inflammation and redox pathways following LPS challenge.Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.A Slow- Compared with a Fast-Release Form of Oral Arginine Increases Its Utilization for Nitric Oxide Synthesis in Overweight Adults with Cardiometabolic Risk Factors in a Randomized Controlled Study.Toward metabolomic signatures of cardiovascular disease.
P2860
Q23909545-DEBF9077-E758-4572-90F6-259C021DEA02Q26751338-8F7B7A52-BB09-448C-9FD3-4CD914861105Q27022359-ED79BA84-BDC3-453A-9924-C563A030E37EQ27309881-E1941AAC-C5AD-4E5E-8109-751F6D7CEFE9Q27324181-9671AE7F-36FF-4D1F-A0D2-ECF46048A477Q28382948-5D6F14EF-2A2F-4255-B640-2AE9FC418B0EQ28386943-BA879C93-6E00-4B97-A0E8-E17E83C98A4BQ28391826-4D014B02-AD03-46B8-8974-E0889238F306Q28395387-CF3AB4B2-0BC9-4891-ABB8-B10B1C9F95A5Q28396137-7085CA49-805F-4418-9C97-82F13EB427A8Q31139529-C9F2E13C-6EA2-41F2-A347-A3F221D226FFQ34118474-EDBCB4D3-A383-4916-AB37-CF9622E8FC70Q34544613-C1E45BEC-CC41-4C57-BE67-CDFDC856469FQ34934327-BB957F97-6333-4D72-A75C-382D8423C14FQ35111227-2CAB2706-9C46-4118-B399-08FFE4129646Q35219088-2E66C44A-ECB1-407A-8F71-49AFBDFBD70BQ35902581-234E444E-CBBC-4CD8-BE39-E6951D31B774Q36117465-DB2AEC45-74F4-4436-BD24-AE7E3067098FQ36296008-6B7F4590-D1A5-42B1-9EAB-0DC01B3B4F49Q36303871-1C203B9E-5CC1-4D30-950A-0107288273B0Q36454194-B27157A1-10A4-482C-AD27-81517C851E67Q36540437-B29326F4-07B8-4B35-92FA-996833C08EAEQ36590608-B41095D8-FD84-444D-B446-5205C3EDB3C1Q36593515-7074F514-DFAD-4C58-833E-B1B5CED62940Q36668659-29775BAA-E7BF-4A22-B803-A30A02523759Q37052539-FCD06D95-7905-490B-8D4C-124D05D1AEBAQ37094822-A8367056-8F6D-485B-A359-84BA892A7DCBQ37144856-5991771F-02EA-496B-AAC9-C4B69B9C4C8EQ37144863-CA20335A-6DA5-4B15-94BA-307398ACE4DDQ37220937-730D56E5-0AC1-4A0F-B264-376850674699Q37370528-D46EDC8B-E764-4D1A-A478-367E455A27EAQ37817050-A39B7F2E-4E7E-4487-8EE9-D38D77368B47Q38028672-4BE31469-BA54-435C-985A-C27E28A4839AQ38586900-0BED4349-37B9-45E2-AF20-5EE5D53C3E49Q38851122-86A31338-CBF5-423C-A8AF-04B263D9D381Q39226887-D7D1424D-2531-49B8-A9E2-F8824FFC5395Q39266063-166AAE56-875F-4F35-84CE-4FC4D63FAA8AQ40421789-C48B4A43-4169-4EFB-AC1A-DF9037190747Q40709849-75DBE63E-2D60-4C91-8D2B-AB122CCE8921Q42554863-02C90B1E-A405-4300-9D67-964B8C6C9DD6
P2860
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diminished global arginine bio ...... increased cardiovascular risk
@en
Diminished global arginine bio ...... increased cardiovascular risk.
@nl
type
label
Diminished global arginine bio ...... increased cardiovascular risk
@en
Diminished global arginine bio ...... increased cardiovascular risk.
@nl
prefLabel
Diminished global arginine bio ...... increased cardiovascular risk
@en
Diminished global arginine bio ...... increased cardiovascular risk.
@nl
P2093
P2860
P1476
Diminished global arginine bio ...... increased cardiovascular risk
@en
P2093
Leslie Cho
Stanley L Hazen
W H Wilson Tang
Zeneng Wang
P2860
P304
P356
10.1016/J.JACC.2009.02.036
P407
P577
2009-06-01T00:00:00Z